The Role of Revascularization Versus Medical Therapy in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2010-01-22

AUTHORS

Brian J. Page, Dmitriy Kireyev, William E. Boden

ABSTRACT

Patients with type 2 diabetes mellitus (T2DM) are at increased risk for cardiovascular clinical events, adverse nonfatal outcomes, and death. There has been considerable improvement in the medical management of patients with T2DM in an attempt to alter the metabolic cascade that is triggered by insulin resistance. Recent trials have demonstrated that medical management of patients with diabetes mellitus and stable coronary artery disease (CAD) is equivalent to revascularization in terms of morality benefit and rates of major adverse cardiovascular events, particularly in patients who do not have extensive CAD. Nonetheless, in those diabetic patients with additional high-risk features including left main disease, reduced left ventricular ejection fraction (LVEF), severe ischemia, or acute coronary syndrome, revascularization remains the best treatment option. Although the evidence still supports coronary artery bypass grafting (CABG) as the standard of care for revascularization of diabetic patients with multivessel CAD and/or reduced LVEF, percutaneous coronary intervention (PCI) with drug-eluting stents (DES) has resulted in at least partial closure of the gap in benefit between surgery and catheter-based intervention. Ongoing trials of diabetic patients with CAD randomized to PCI or CABG will help further elucidate the role of PCI with DES as a potential revascularization option for this patient population. More... »

PAGES

10-15

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11892-009-0091-9

DOI

http://dx.doi.org/10.1007/s11892-009-0091-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1030029159

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20425061


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angioplasty, Balloon, Coronary", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Coronary Artery Bypass", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Coronary Artery Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myocardial Revascularization", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Cardiology, Buffalo General Hospital, 100 High Street, 14203, Buffalo, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.413119.f", 
          "name": [
            "Division of Cardiology, Buffalo General Hospital, 100 High Street, 14203, Buffalo, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Page", 
        "givenName": "Brian J.", 
        "id": "sg:person.01101573464.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101573464.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cardiology, Buffalo General Hospital, 100 High Street, 14203, Buffalo, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.413119.f", 
          "name": [
            "Division of Cardiology, Buffalo General Hospital, 100 High Street, 14203, Buffalo, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kireyev", 
        "givenName": "Dmitriy", 
        "id": "sg:person.0745731237.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0745731237.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cardiology, Buffalo General Hospital, 100 High Street, 14203, Buffalo, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.413119.f", 
          "name": [
            "Division of Cardiology, Buffalo General Hospital, 100 High Street, 14203, Buffalo, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boden", 
        "givenName": "William E.", 
        "id": "sg:person.01162454534.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162454534.35"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2010-01-22", 
    "datePublishedReg": "2010-01-22", 
    "description": "Patients with type 2 diabetes mellitus (T2DM) are at increased risk for cardiovascular clinical events, adverse nonfatal outcomes, and death. There has been considerable improvement in the medical management of patients with T2DM in an attempt to alter the metabolic cascade that is triggered by insulin resistance. Recent trials have demonstrated that medical management of patients with diabetes mellitus and stable coronary artery disease (CAD) is equivalent to revascularization in terms of morality benefit and rates of major adverse cardiovascular events, particularly in patients who do not have extensive CAD. Nonetheless, in those diabetic patients with additional high-risk features including left main disease, reduced left ventricular ejection fraction (LVEF), severe ischemia, or acute coronary syndrome, revascularization remains the best treatment option. Although the evidence still supports coronary artery bypass grafting (CABG) as the standard of care for revascularization of diabetic patients with multivessel CAD and/or reduced LVEF, percutaneous coronary intervention (PCI) with drug-eluting stents (DES) has resulted in at least partial closure of the gap in benefit between surgery and catheter-based intervention. Ongoing trials of diabetic patients with CAD randomized to PCI or CABG will help further elucidate the role of PCI with DES as a potential revascularization option for this patient population.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11892-009-0091-9", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1028990", 
        "issn": [
          "1534-4827", 
          "1539-0829"
        ], 
        "name": "Current Diabetes Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "10"
      }
    ], 
    "keywords": [
      "left ventricular ejection fraction", 
      "coronary artery disease", 
      "percutaneous coronary intervention", 
      "drug-eluting stents", 
      "diabetic patients", 
      "diabetes mellitus", 
      "artery disease", 
      "medical management", 
      "role of PCI", 
      "stable coronary artery disease", 
      "major adverse cardiovascular events", 
      "extensive coronary artery disease", 
      "additional high-risk features", 
      "multivessel coronary artery disease", 
      "type 2 diabetes mellitus", 
      "cardiovascular clinical events", 
      "adverse cardiovascular events", 
      "coronary artery bypass", 
      "high-risk features", 
      "ventricular ejection fraction", 
      "acute coronary syndrome", 
      "best treatment option", 
      "standard of care", 
      "catheter-based interventions", 
      "cardiovascular events", 
      "artery bypass", 
      "revascularization options", 
      "coronary syndrome", 
      "coronary intervention", 
      "nonfatal outcomes", 
      "ejection fraction", 
      "ongoing trials", 
      "medical therapy", 
      "severe ischemia", 
      "clinical events", 
      "insulin resistance", 
      "treatment options", 
      "patient population", 
      "recent trials", 
      "patients", 
      "type 2", 
      "revascularization", 
      "mellitus", 
      "main disease", 
      "disease", 
      "metabolic cascade", 
      "trials", 
      "intervention", 
      "least partial closure", 
      "partial closure", 
      "CABG", 
      "T2DM", 
      "ischemia", 
      "surgery", 
      "options", 
      "syndrome", 
      "bypass", 
      "therapy", 
      "stents", 
      "care", 
      "death", 
      "outcomes", 
      "management", 
      "risk", 
      "role", 
      "benefits", 
      "events", 
      "population", 
      "closure", 
      "evidence", 
      "cascade", 
      "rate", 
      "improvement", 
      "resistance", 
      "considerable improvement", 
      "fraction", 
      "standards", 
      "features", 
      "attempt", 
      "terms", 
      "gap", 
      "adverse nonfatal outcomes", 
      "morality benefit", 
      "potential revascularization option", 
      "Revascularization Versus Medical Therapy", 
      "Versus Medical Therapy"
    ], 
    "name": "The Role of Revascularization Versus Medical Therapy in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease", 
    "pagination": "10-15", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1030029159"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11892-009-0091-9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20425061"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11892-009-0091-9", 
      "https://app.dimensions.ai/details/publication/pub.1030029159"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:23", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_512.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11892-009-0091-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11892-009-0091-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11892-009-0091-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11892-009-0091-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11892-009-0091-9'


 

This table displays all metadata directly associated to this object as RDF triples.

190 TRIPLES      21 PREDICATES      119 URIs      110 LITERALS      13 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11892-009-0091-9 schema:about N41bca3ffe6944c57bc1cc081e440c4b2
2 N907537dd47f64301b3b736d02a26b41a
3 N96cdbad1af654eedbb7e7fcd0150cc62
4 Na1c51d38824349cfb5a3962ae02cb9ab
5 Nb75427c0a8dc443ebed346771b88e2b7
6 Nd0732f5bcc174493ab0e7244fdd3897c
7 anzsrc-for:11
8 anzsrc-for:1102
9 anzsrc-for:1103
10 schema:author N657b7ccb07224c73a9d07cae1dcc5011
11 schema:datePublished 2010-01-22
12 schema:datePublishedReg 2010-01-22
13 schema:description Patients with type 2 diabetes mellitus (T2DM) are at increased risk for cardiovascular clinical events, adverse nonfatal outcomes, and death. There has been considerable improvement in the medical management of patients with T2DM in an attempt to alter the metabolic cascade that is triggered by insulin resistance. Recent trials have demonstrated that medical management of patients with diabetes mellitus and stable coronary artery disease (CAD) is equivalent to revascularization in terms of morality benefit and rates of major adverse cardiovascular events, particularly in patients who do not have extensive CAD. Nonetheless, in those diabetic patients with additional high-risk features including left main disease, reduced left ventricular ejection fraction (LVEF), severe ischemia, or acute coronary syndrome, revascularization remains the best treatment option. Although the evidence still supports coronary artery bypass grafting (CABG) as the standard of care for revascularization of diabetic patients with multivessel CAD and/or reduced LVEF, percutaneous coronary intervention (PCI) with drug-eluting stents (DES) has resulted in at least partial closure of the gap in benefit between surgery and catheter-based intervention. Ongoing trials of diabetic patients with CAD randomized to PCI or CABG will help further elucidate the role of PCI with DES as a potential revascularization option for this patient population.
14 schema:genre article
15 schema:inLanguage en
16 schema:isAccessibleForFree false
17 schema:isPartOf N489ea97e68694541857a3650ade4eda2
18 Ndc0acf49c2024ff79f2bc9418a779076
19 sg:journal.1028990
20 schema:keywords CABG
21 Revascularization Versus Medical Therapy
22 T2DM
23 Versus Medical Therapy
24 acute coronary syndrome
25 additional high-risk features
26 adverse cardiovascular events
27 adverse nonfatal outcomes
28 artery bypass
29 artery disease
30 attempt
31 benefits
32 best treatment option
33 bypass
34 cardiovascular clinical events
35 cardiovascular events
36 care
37 cascade
38 catheter-based interventions
39 clinical events
40 closure
41 considerable improvement
42 coronary artery bypass
43 coronary artery disease
44 coronary intervention
45 coronary syndrome
46 death
47 diabetes mellitus
48 diabetic patients
49 disease
50 drug-eluting stents
51 ejection fraction
52 events
53 evidence
54 extensive coronary artery disease
55 features
56 fraction
57 gap
58 high-risk features
59 improvement
60 insulin resistance
61 intervention
62 ischemia
63 least partial closure
64 left ventricular ejection fraction
65 main disease
66 major adverse cardiovascular events
67 management
68 medical management
69 medical therapy
70 mellitus
71 metabolic cascade
72 morality benefit
73 multivessel coronary artery disease
74 nonfatal outcomes
75 ongoing trials
76 options
77 outcomes
78 partial closure
79 patient population
80 patients
81 percutaneous coronary intervention
82 population
83 potential revascularization option
84 rate
85 recent trials
86 resistance
87 revascularization
88 revascularization options
89 risk
90 role
91 role of PCI
92 severe ischemia
93 stable coronary artery disease
94 standard of care
95 standards
96 stents
97 surgery
98 syndrome
99 terms
100 therapy
101 treatment options
102 trials
103 type 2
104 type 2 diabetes mellitus
105 ventricular ejection fraction
106 schema:name The Role of Revascularization Versus Medical Therapy in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
107 schema:pagination 10-15
108 schema:productId N56d393e75e914e848f5eb36e76fc84c4
109 N684afdbedc3f436f89b0df0019a91beb
110 Na7d448d05a5044559b54cd714f9eb6cc
111 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030029159
112 https://doi.org/10.1007/s11892-009-0091-9
113 schema:sdDatePublished 2021-12-01T19:23
114 schema:sdLicense https://scigraph.springernature.com/explorer/license/
115 schema:sdPublisher N948e7c6924c64e28827a26de957b8a93
116 schema:url https://doi.org/10.1007/s11892-009-0091-9
117 sgo:license sg:explorer/license/
118 sgo:sdDataset articles
119 rdf:type schema:ScholarlyArticle
120 N125790c0f9014c129c2d69362d6f6289 rdf:first sg:person.0745731237.26
121 rdf:rest N74a9fbedc5324e14853f8c1a06a26a88
122 N41bca3ffe6944c57bc1cc081e440c4b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Coronary Artery Bypass
124 rdf:type schema:DefinedTerm
125 N489ea97e68694541857a3650ade4eda2 schema:volumeNumber 10
126 rdf:type schema:PublicationVolume
127 N56d393e75e914e848f5eb36e76fc84c4 schema:name doi
128 schema:value 10.1007/s11892-009-0091-9
129 rdf:type schema:PropertyValue
130 N657b7ccb07224c73a9d07cae1dcc5011 rdf:first sg:person.01101573464.76
131 rdf:rest N125790c0f9014c129c2d69362d6f6289
132 N684afdbedc3f436f89b0df0019a91beb schema:name pubmed_id
133 schema:value 20425061
134 rdf:type schema:PropertyValue
135 N74a9fbedc5324e14853f8c1a06a26a88 rdf:first sg:person.01162454534.35
136 rdf:rest rdf:nil
137 N907537dd47f64301b3b736d02a26b41a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Diabetes Mellitus, Type 2
139 rdf:type schema:DefinedTerm
140 N948e7c6924c64e28827a26de957b8a93 schema:name Springer Nature - SN SciGraph project
141 rdf:type schema:Organization
142 N96cdbad1af654eedbb7e7fcd0150cc62 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Coronary Artery Disease
144 rdf:type schema:DefinedTerm
145 Na1c51d38824349cfb5a3962ae02cb9ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Angioplasty, Balloon, Coronary
147 rdf:type schema:DefinedTerm
148 Na7d448d05a5044559b54cd714f9eb6cc schema:name dimensions_id
149 schema:value pub.1030029159
150 rdf:type schema:PropertyValue
151 Nb75427c0a8dc443ebed346771b88e2b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Myocardial Revascularization
153 rdf:type schema:DefinedTerm
154 Nd0732f5bcc174493ab0e7244fdd3897c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Humans
156 rdf:type schema:DefinedTerm
157 Ndc0acf49c2024ff79f2bc9418a779076 schema:issueNumber 1
158 rdf:type schema:PublicationIssue
159 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
160 schema:name Medical and Health Sciences
161 rdf:type schema:DefinedTerm
162 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
163 schema:name Cardiorespiratory Medicine and Haematology
164 rdf:type schema:DefinedTerm
165 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
166 schema:name Clinical Sciences
167 rdf:type schema:DefinedTerm
168 sg:journal.1028990 schema:issn 1534-4827
169 1539-0829
170 schema:name Current Diabetes Reports
171 schema:publisher Springer Nature
172 rdf:type schema:Periodical
173 sg:person.01101573464.76 schema:affiliation grid-institutes:grid.413119.f
174 schema:familyName Page
175 schema:givenName Brian J.
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101573464.76
177 rdf:type schema:Person
178 sg:person.01162454534.35 schema:affiliation grid-institutes:grid.413119.f
179 schema:familyName Boden
180 schema:givenName William E.
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162454534.35
182 rdf:type schema:Person
183 sg:person.0745731237.26 schema:affiliation grid-institutes:grid.413119.f
184 schema:familyName Kireyev
185 schema:givenName Dmitriy
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0745731237.26
187 rdf:type schema:Person
188 grid-institutes:grid.413119.f schema:alternateName Division of Cardiology, Buffalo General Hospital, 100 High Street, 14203, Buffalo, NY, USA
189 schema:name Division of Cardiology, Buffalo General Hospital, 100 High Street, 14203, Buffalo, NY, USA
190 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...